A Complex Case of Undiagnosed Generalised Anxiety Disorder with Episodic Panic Attacks

Apr 12, 2018 by in PSYCHIATRY Comments Off on A Complex Case of Undiagnosed Generalised Anxiety Disorder with Episodic Panic Attacks

© Springer International Publishing Switzerland 2017David Camfield, Erica McIntyre and Jerome Sarris (eds.)Evidence-Based Herbal and Nutritional Treatments for Anxiety in Psychiatric Disorders10.1007/978-3-319-42307-4_11 11. A Complex Case of Undiagnosed Generalised Anxiety Disorder with Episodic Panic Attacks Jane Hutchens1  …

read more

SAMe in the Treatment of Refractory Depression with Comorbid Anxiety: A Case Study in a High Histamine Patient

Apr 12, 2018 by in PSYCHIATRY Comments Off on SAMe in the Treatment of Refractory Depression with Comorbid Anxiety: A Case Study in a High Histamine Patient

Differential naturopathic diagnoses Supportive evidence Counter-indications Monoamine theory of depression, e.g. low serotonin Presents with depression and anxiety Lack of efficacy of SSRIs and TCAs Neuro-inflammation Long-term detectable CRP Elevated…

read more

Potential Herbal Anxiolytics

Apr 12, 2018 by in PSYCHIATRY Comments Off on Potential Herbal Anxiolytics

Herbal medicine Dosage Major/active constituents Key evidence Potential AEs Potential clinical use Clinical advice Bitter orange (Citrus aurantium) Acute dose: 1 ml/kg of distillate; standardized for linalool, total phenolic acids,…

read more

Herbal Anxiolytics with Sedative Actions

Apr 12, 2018 by in PSYCHIATRY Comments Off on Herbal Anxiolytics with Sedative Actions

Herbal medicine Dosage Major/active constituents Key evidence Potential AEs Potential clinical use Clinical advice Kava (Piper methysticum) Total dose of 50–250 mg of kavalactonesper day, approximating 50–60 mg of kavalactones…

read more

Cognitive Anxiolytics

Apr 12, 2018 by in PSYCHIATRY Comments Off on Cognitive Anxiolytics

Herbal medicine Dosage Major/active constituents Key evidence Potential adverse effects Potential clinical use Clinical advice Brahmi (Bacopa monnieri) Acute: 320 mg or 640 mg of Brahmi extract Chronic: 300 mg/d…

read more

Adaptogens

Apr 12, 2018 by in PSYCHIATRY Comments Off on Adaptogens

Herbal medicine Dosage Major/active constituents Key evidence PotentialAEs Potentialclinical use Clinical advice Ashwagandha (Withania somnifera) Total dose of 500–1000 mg/day dried extract standardised to withanolides, or 4–6 g/day root powder…

read more

The Need for Evidence-Based Herbal and Nutritional Anxiety Treatments in Psychiatry

Apr 12, 2018 by in PSYCHIATRY Comments Off on The Need for Evidence-Based Herbal and Nutritional Anxiety Treatments in Psychiatry

© Springer International Publishing Switzerland 2017David Camfield, Erica McIntyre and Jerome Sarris (eds.)Evidence-Based Herbal and Nutritional Treatments for Anxiety in Psychiatric Disorders10.1007/978-3-319-42307-4_1 1. The Need for Evidence-Based Herbal and Nutritional Anxiety Treatments in Psychiatry David A. Camfield1, 2  ,…

read more

The Therapeutic Potential of Ayahuasca

Apr 12, 2018 by in PSYCHIATRY Comments Off on The Therapeutic Potential of Ayahuasca

Herbal medicine Dosage Major/Active Constituents Key evidence Potential AEs Potential clinical use Clinical advice Ayahuasca ( Psychotria viridis plus Banisteriopsis caapi; or B. caapi plus Diplopterys cabrerana) Variable dosage MAOI:…

read more

Treatments for Comorbid Anxiety and Mood Disorders

Apr 12, 2018 by in PSYCHIATRY Comments Off on Treatments for Comorbid Anxiety and Mood Disorders

Nutraceutical Dosage Major/active constituents Key evidence Potential AEs Potential clinical use Clinical advice St John’s wort (Hypericum perforatum) 1 mg of hypericin per day (one or two times per day);…

read more
Get Clinical Tree app for offline access